Naba Al Saha Medical Services Company (TADAWUL:9546)
Saudi Arabia · Delayed Price · Currency is SAR 22.00
-1.00 (-4.35%)
Jun 11, 2026, 3:19 PM AST
TADAWUL:9546 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 201.81 | 194.28 | 182.35 | 129.68 | 117.68 | |
Revenue Growth (YoY) | 3.88% | 6.54% | 40.61% | 10.20% | 1.73% |
Cost of Revenue | 138.48 | 134.29 | 110.57 | 79.8 | 72.32 |
Gross Profit | 63.33 | 60 | 71.78 | 49.88 | 45.36 |
Selling, General & Admin | 30.97 | 32.05 | 27.94 | 19.32 | 17.54 |
Operating Expenses | 30.97 | 34.73 | 27.94 | 20.07 | 17.54 |
Operating Income | 32.36 | 25.27 | 43.84 | 29.81 | 27.82 |
Interest Expense | -0.1 | -0.19 | -0.21 | -0.21 | -0.25 |
Interest & Investment Income | 1.03 | 0.73 | 0.05 | - | - |
Earnings From Equity Investments | -0.67 | -1.5 | -0.72 | -0.13 | - |
Other Non Operating Income (Expenses) | -1.8 | 0.38 | 2.24 | -0.53 | -0.04 |
EBT Excluding Unusual Items | 30.82 | 24.69 | 45.21 | 28.93 | 27.53 |
Gain (Loss) on Sale of Investments | -0.19 | 0.37 | - | - | - |
Asset Writedown | - | - | 2.33 | - | - |
Other Unusual Items | - | - | 7.33 | - | - |
Pretax Income | 30.64 | 25.06 | 54.86 | 28.93 | 27.53 |
Income Tax Expense | 3.11 | 3.27 | 2.48 | 2.01 | 1.7 |
Net Income | 27.53 | 21.78 | 52.38 | 26.92 | 25.83 |
Net Income to Common | 27.53 | 21.78 | 52.38 | 26.92 | 25.83 |
Net Income Growth | 26.37% | -58.41% | 94.57% | 4.24% | -3.10% |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 |
EPS (Basic) | 1.31 | 1.04 | 2.49 | 1.28 | 1.23 |
EPS (Diluted) | 1.31 | 1.04 | 2.49 | 1.28 | 1.23 |
EPS Growth | 26.37% | -58.41% | 94.57% | 4.24% | - |
Free Cash Flow | -43.23 | -1.83 | -9.51 | 27.95 | 20.37 |
Free Cash Flow Per Share | -2.06 | -0.09 | -0.45 | 1.33 | 0.97 |
Dividend Per Share | - | 0.150 | - | 0.100 | 0.100 |
Gross Margin | 31.38% | 30.88% | 39.36% | 38.46% | 38.55% |
Operating Margin | 16.04% | 13.00% | 24.04% | 22.98% | 23.64% |
Profit Margin | 13.64% | 11.21% | 28.73% | 20.76% | 21.95% |
Free Cash Flow Margin | -21.42% | -0.94% | -5.21% | 21.55% | 17.31% |
EBITDA | 42.14 | 34.36 | 51.53 | 35 | 32.47 |
EBITDA Margin | 20.88% | 17.69% | 28.26% | 26.99% | 27.59% |
D&A For EBITDA | 9.78 | 9.1 | 7.68 | 5.2 | 4.65 |
EBIT | 32.36 | 25.27 | 43.84 | 29.81 | 27.82 |
EBIT Margin | 16.04% | 13.00% | 24.04% | 22.98% | 23.64% |
Effective Tax Rate | 10.15% | 13.06% | 4.52% | 6.95% | 6.18% |